$0.59
0.00 (-0.62%)
Open$0.57
Previous Close$0.60
Day High$0.64
Day Low$0.56
52W High$7.20
52W Low$0.46
Volume—
Avg Volume471.7K
Market Cap11.93M
P/E Ratio—
EPS$-1.29
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+6,084.3% upside
Current
$0.59
$0.59
Target
$36.71
$36.71
$29.06
$36.71 avg
$43.55
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.85M | 1.83M | 1.75M |
| Net Income | 558.6K | 478.0K | 437.1K |
| Profit Margin | 30.2% | 26.2% | 25.0% |
| EBITDA | 671.1K | 736.1K | 607.5K |
| Free Cash Flow | 473.4K | 406.9K | 399.5K |
| Rev Growth | +1.8% | +20.8% | +4.5% |
| Debt/Equity | 0.11 | 0.11 | 0.14 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,124.85 | +0.68% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $245.14 | +1.72% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $124.71 | +3.41% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $23.83 | -0.87% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.00 | -0.95% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $77.65 | -0.67% | 12.5 | 33.00B |